Медицинская химия

New Medication Limits Harm after a Coronary Failure by 60 Percent

Abstract

Sowmya Uttam

Domainex is satisfied to declare that a group of its researchers, working in close organization with Professor Michael Schneider and his group at Imperial College have discovered a possible new medication for treating the heart harm brought about by a cardiovascular failure by focusing on the manner in which the heart responds to pressure. The examination was distributed in the diary, Cell Stem Cell, and was part-financed by the British Heart Foundation (BHF). The examination group utilized undifferentiated cells to develop heart tissue and copy a 'coronary failure in a dish' and had the option to obstruct the synthetic signs inside heart muscle that lead to cell passing and heart harm.